DEFA14A ·Filed Apr 28, 2026

ANIK

Anika Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago SEC0001140361-26-017489
Proxy solicitation materials
Actionable Insight • Neutral

The DEFA14A filing lacks substantive content; monitor for the definitive proxy statement (DEF 14A) or subsequent filings to identify any shareholder vote or activist activity.

DirectionNeutral
Confidencelow
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
ANIK ▲ +20.66% at T+60d
NEUTRAL call ✓ call won +20.66% · α vs SPY +16.55% · entry $12.39 → $14.95
Entry anchored
Apr 28, 2026
via day open
T+1d
+0.48%
call +0.48% · α -0.54%
$12.45
settled 5mo ago
T+5d
+22.03%
call +22.03% · α +18.92%
$15.12
settled 5mo ago
T+20d
+20.26%
call +20.26% · α +14.21%
$14.90
settled 4mo ago
T+60d
+20.66%
call +20.66% · α +16.55%
$14.95
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Anika Therapeutics filed a DEFA14A (additional definitive proxy soliciting materials) with no substantive financial or voting details disclosed in the available text. The filing appears to be a routine supplement to proxy materials, but without content, no material impact can be assessed.

Key Facts

  • Filing Type: DEFA14A (Additional definitive proxy soliciting materials)
  • Filed by Registrant (Anika Therapeutics, Inc.)
  • No financial data, vote outcomes, or material disclosures in the document text

Financial Impact

Not specified

Risk Factors

  • Lack of transparency; potential for undisclosed proxy contest or material vote
  • Possible activist involvement given cross-filing context, but unconfirmed

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001140361-26-017489
Document: 0001140361-26-017489-index-headers.html0001140361-26-017489
Document: 0001140361-26-017489-index.html0001140361-26-017489
Document: 0001140361-26-017489.txt0001140361-26-017489
11 reports for ANIK
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for ANIK — sortable, filterable
TypeNow
Jul 29, 2026
9w ago
8-K
BULLISH ★ 8/10
$16.17 $21.68▲ +34.08%▲ +29.06%$19.10 (+18.12%)
Jul 14, 2026
11w ago
8-K
NEUTRAL ★ 3/10
$15.93 $22.03▲ +38.29%▲ +35.95%$19.10 (+19.90%)
Jun 23, 2026
14w ago
8-K
NEUTRAL ★ 4/10
$14.73 $15.01▲ +1.90%▼ −0.03%$19.10 (+29.67%)
Jun 11, 2026
16w ago
Institutional Cluster
BEARISH ★ 4/10
$14.72 $15.60▼ −5.98%▼ −4.20%$19.10 (−29.76%)
Jun 8, 2026
16w ago
DEFA14A
NEUTRAL ★ 4/10
$14.60 $16.03▲ +9.79%▲ +8.16%$19.10 (+30.82%)
Jun 1, 2026
17w ago
DEFA14A
NEUTRAL ★ 3/10
$14.63 $14.63· 0.00%▲ +1.30%$19.10 (+30.55%)
Apr 30, 2026
22w ago
Insider Cluster
MIXED ★ 5/10
$12.45 $14.90▲ +19.68%▲ +14.71%$19.10 (+53.41%)
Apr 29, 2026
22w ago
8-K
MIXED ★ 6/10
$12.39 $14.90▲ +20.26%▲ +14.21%$19.10 (+54.16%)
Apr 28, 2026
22w ago
DEFA14A
NEUTRAL ★ 2/10
$12.39 $14.90▲ +20.26%▲ +14.21%$19.10 (+54.16%)
Apr 15, 2026
24w ago
Press Release
NEUTRAL ★ 3/10
$15.39 $14.80▼ −3.83%▼ −9.65%$19.10 (+24.11%)
Showing 10 of 11

US Market Status

Market Closed — Opens Mon (65h 23m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access